Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.

Clinical trial NCT03944499 · COMPLETED

Trial details

NCT number: NCT03944499
Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Breast Cancer

Start date: 2019-10-11
Primary completion: 2024-05-20
Enrollment: 161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.